Thinking about what to do with Recursion Pharmaceuticals stock right now? You are not alone. In just the past week, the stock has jumped an impressive 19.2%, adding to an 18.5% surge over 30 days. It ...

If it can bounce back and generate solid returns in the next five years, now is about as good a time as any to invest in the ...

Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...

It’s a sign that’s impossible to ignore. As you soon as you pull up the Price Overview for Recursion Pharmaceuticals (RXRX), ...

The vast majority of experimental drugs that enter clinical trials never become marketable products, but by applying AI to ...

For one thing, BigBear.ai's revenue plunged 18% year over year in the second quarter of 2025. While Diebold Nixdorf's revenue ...

Recursive digital selves underpin targeted advertising, predictive policing, and workplace monitoring. In each case, the ...

Deemos Tech, a leading 3D generative AI company, today announced the landmark launch of Hyper3D Rodin Gen-2, its ...

Recursion Pharmaceuticals (RXRX) closed at $4.77 in the latest trading session, marking a -1.24% move from the prior day. This change lagged the S&P 500's 0.47% gain on the day. Meanwhile, the Dow ...